2型糖尿病心血管和肾脏预后的改善:血糖控制的作用，而不是药物的作用

Journal of diabetes, metabolic disorders & control Pub Date : 2021-09-24 DOI:10.15406/JDMDC.2021.08.00225

U. Kabadi

{"title":"2型糖尿病心血管和肾脏预后的改善:血糖控制的作用，而不是药物的作用","authors":"U. Kabadi","doi":"10.15406/JDMDC.2021.08.00225","DOIUrl":null,"url":null,"abstract":"because of lack of administration of equivalent daily doses in drug naive subjects. Moreover, the data regarding impact of new drugs on cardiovascular and renal outcomes is overstated as these trials demonstrate no additional improvement beyond that achieved by improvement in glycemic control. Finally","PeriodicalId":92240,"journal":{"name":"Journal of diabetes, metabolic disorders & control","volume":"27 1","pages":"76-77"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Improvement in cardiovascular and renal outcomes in type 2 diabetes: effect of glycemic control, not drugs\",\"authors\":\"U. Kabadi\",\"doi\":\"10.15406/JDMDC.2021.08.00225\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"because of lack of administration of equivalent daily doses in drug naive subjects. Moreover, the data regarding impact of new drugs on cardiovascular and renal outcomes is overstated as these trials demonstrate no additional improvement beyond that achieved by improvement in glycemic control. Finally\",\"PeriodicalId\":92240,\"journal\":{\"name\":\"Journal of diabetes, metabolic disorders & control\",\"volume\":\"27 1\",\"pages\":\"76-77\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of diabetes, metabolic disorders & control\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/JDMDC.2021.08.00225\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of diabetes, metabolic disorders & control","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/JDMDC.2021.08.00225","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

因为在初次用药的受试者中缺乏等量的日剂量。此外，关于新药对心血管和肾脏预后影响的数据被夸大了，因为这些试验表明，除了改善血糖控制外，没有其他改善。最后

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Improvement in cardiovascular and renal outcomes in type 2 diabetes: effect of glycemic control, not drugs

because of lack of administration of equivalent daily doses in drug naive subjects. Moreover, the data regarding impact of new drugs on cardiovascular and renal outcomes is overstated as these trials demonstrate no additional improvement beyond that achieved by improvement in glycemic control. Finally

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of diabetes, metabolic disorders & control

自引率

0.00%

发文量